T-lymphoblastic Leukemia Lymphoma
📧 Sign up to get email alerts when something new happens for T-lymphoblastic Leukemia Lymphoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-09-19Clinical Trial Update: Romidepsin Maintenance After Allogeneic Stem Cell Transplantation [Phase 1]
Phase 1 trial update on romidepsin as maintenance therapy after allogeneic stem cell transplantation. The study status is completed and incl…
-
CLINICAL_TRIALS trial_result · 2025-06-06Clinical Trial Update: Anti-CD7 CAR-T Cell Therapy for Relapse and Refractory CD7 Positive T Cell Malignancies [Phase 1]
Phase 1 trial evaluating anti-CD7 CAR-T cell therapy for relapsed/refractory CD7-positive T-cell malignancies has completed, assessing safet…
-
CLINICAL_TRIALS trial_result · 2025-05-18Clinical Trial Update: Multi-centers, Open-Label, Phase 2 Study to Evaluate the Efficacy and Safety of Donor-Derived CD7 CAR T Cells in Subjects With Relapsed or Refractory T-cell Leukemia/Lymphoma [Phase 2]
A multi-center, open-label Phase 2 trial evaluating the efficacy and safety of donor-derived CD7 CAR T cells in relapsed or refractory T-cel…